1M. Pharm Student, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu
2,3Assistant Professor Department Of Pharmacology, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu
4Assistant Professor Department Of Pharmaceutics, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu
5Vice Principal, Aadhibhagawan College Of Pharmacy, Rantham, Thiruvannamalai, Tamil Nadu
Cassia fistula, commonly known as "Golden Shower," is a medicinal plant with a wide range of traditional uses. This study aimed to investigate the in vitro anti-inflammatory, antiplatelet, and antioxidant activities of Cassia fistula Linn. leaves. The leaves of Cassia fistula were extracted using an appropriate solvent, and the extract was subjected to in vitro assays to evaluate its potential therapeutic properties. The anti-inflammatory activity was assessed by measuring the inhibition of nitric oxide (NO) production in lipopolysaccharide (LPS)-induced RAW 264.7 macrophages. The antiplatelet activity was determined by evaluating the inhibition of platelet aggregation induced by adenosine diphosphate (ADP) and collagen. The antioxidant activity was evaluated through assays measuring 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging and total antioxidant capacity. The results demonstrated that Cassia fistula leaf extract exhibited significant in vitro anti-inflammatory activity by inhibiting NO production in LPS-induced macrophages. The extract also displayed potent antiplatelet activity by inhibiting platelet aggregation induced by ADP and collagen. Additionally, the extract exhibited remarkable antioxidant activity by effectively scavenging DPPH radicals and demonstrating high total antioxidant capacity. These findings suggest that Cassia fistula leaf extract possesses notable in vitro anti-inflammatory, antiplatelet, and antioxidant activities. These pharmacological properties may contribute to the plant's traditional medicinal uses and highlight its potential as a valuable natural resource for the development of therapeutic interventions. Further investigations are required to identify and isolate the bioactive compounds responsible for the observed activities and to explore their mechanisms of action.
Inflammatory diseases are probably the most common diseases in the century. Inflammation is the crucial first step in fighting off infection and healing wounds, which is a defence mechanism of the body. When inflammation persists immune system is always activated. This is known as chronic inflammation and can lead to chronic diseases. In some diseases the body’s defence system (immune system) inappropriately triggers an inflammatory response even when there are no foreign body’s to fight off. These diseases are called as autoimmune diseases. This can cause myocarditis, asthma attack and nephritis resulting in high blood pressure or kidney failure and colitis. Many diseases are associated with inflammation like Alzheimer’s diseases, heart diseases, diabetes, cancer and arthritis. Thus it becomes essential to prevent inflammation.
Platelet function is connected with inflammatory process and various free radicals are associated with diseases that alter the functions of platelets and bring inflammation. Platelets localize with leukocytes at sites of hemorrhage, within atherosclerotic and post angioplasty restenosis lesions and on areas of ischemic reperfusion injury. This heterotypic interaction between platelets and leukocytes links haemostatic/thrombotic and inflammatory responses. Thus we can regard anti inflammatory therapies as potentially antithrombotic. A vast amount of circumstantial evidence implicates oxygen derived free radicals, especially ROS and NO as mediators of inflammation and/or tissue destruction in inflammation and arthritic disorders. Massive burst of ROS during ischemia/reperfusion in turn lead to tissue injury causing serious complications in organ transplantation, stroke and myocardial infarction.
Though there are many synthetic drugs available for the treatment of inflammation and prevent platelet aggregation they all have side effects associated with their uses. Herbal formulations are considered to be less toxic and also free from their side effects than synthetic ones. Numerous plants are claimed to possess anti-inflammatory, anti-platelet and anti-oxidant phyto constituents in folk medicine, however one among them is Cassia fistula Linn leaves. Since there are no specific scientific reports regarding its use as anti-inflammatory, anti-platelet and antioxidant activities, the plant was selected for this particular study with the aim to bring scientific evidence for its therapeutic uses. The main objective of the present study is to evaluate the anti-inflammatory, anti-platelet and antioxidant activities of Cassia fistula Linn leaves using various in vitro models. The scope of the study is attributed in exploring the potentials of the bioactive compounds from the medicinal trees and in revealing its safety & efficacy, there by realizing the promising ethno botanical herbs, towards the development of phyto medicine.
2.2 Description:
The tree is 6-9 m high; trunk straight; bark smooth and pale green when young, rough and dark brown when old; branches spreading slender. Leaves 23-30 cm long; main rhachis pubescent; stipule minute, linear-oblong, obtuse, pubescent. Leaflets 4-8 pairs ovate-oblong, bright green and glabrous above, paler and silvery-pubescent beneath. When young the midrib densely pubescent on the under side, base cuneate. Flowers in lax racemes 30-50 cm long; pedicals 3.8-5.7 cm long, slender, pubescent or glabrous. Calyx 1 cm long, divided to the base, pubescent; segments oblong, obtuse. Corolla 3.8 cm across, yellow; petals 5, subequal, obovate, shortly clawed, veined. Stamens all antheriferous, the 3 lowest the longest with very long curved filaments and oblong anthers dehiscing longitudinally, the 4 lateral with short straight filaments and versatile anthers opening by pores at the base, the remaining 3 much smaller, erect with indehiscent.
2.3 Chemical Constituent:
The Dried leaves of Cassia fistula Linn consists of tannins like Epicatechin, Total Phenolics like Proycanidin B2, Bi-flavonoids, Tri-flavonoids, and Glycosides like Rhein glycosides, Sennoiside A and B, Chrysophanol, Physcion.
2.4 Medicinal Uses:
Fig: 1 Cassia Fistula Linn
MATERIALS AND METHODS
3.1 Drugs and Chemicals:
Lipoxidase Enzyme, Linoleic acid, Tris-HCL Buffer, Ibuprofen, Sodium Citrate, ADP (adenosine-5-diphosphate-dicyclohexyl ammonium salt), DPPH (Diphenyl Picryl Hydrazine), Hydrogen Peroxide, Indomethacin, EDTA, Nitro Blue Tetrazolium (NBT), Dextrose, Citric acid, Ascorbic acid, 2-deoxy2-ribose, Hypoxanthine, Xanthine Oxidase, Butylated Hydroxyl Toluene, Sodium nitroprusside, Curcumin, Quercetin, Ethanol, Ferric Chloride, Potassium Ferricyanide, Sulphanilamide, Phosphoric acid, Ferric chloride, and Thio barbituric acid (TBA).
3.2 Collection and Authentication:
The leaves of Cassis fistula was collected in the Rantham areas, identified and authenticated. The aerial parts of the plant were thoroughly washed with water, in order to remove the earthy materials sticking to it. It was then dried under shade and powdered with a mechanical grinder and sieved through No.20 mesh sieve. The finely powdered leaves were kept in an airtight container until the time of use.
3.3 Preparation Of The Methanol Extract Of Cassia Fistula Linn Leaves:
The methanol extract of the leaves of Cassia fistula Linn was prepared by extraction using cold maceration process. 15g of finely powdered leaves were taken in mortar and triturated with small volume of methanol. A total volume of 150ml of methanol was added and stirred continuously in a mechanical shaker for 4 hours. It was then kept aside for 24 hours. It was again stirred in mechanical shaker for 4 hours kept aside for 12 hours. The contents were taken, filtered through muslin cloth; the filtrate was decanted and evaporated to dryness.
3.4 Preliminary Phytochemical Screening:
3.5 In Vitro Anti-Inflammatory Methods:
3.6 In Vitro Anti-Platelet Activity In Whole Blood:
3.7 In Vitro Antioxidant Studies:
3.8 Statistical Analysis:
All determinations are carried out in triplicate and the values are expressed as mean ± SEM.
RESULTS AND DISCUSSION
Extraction of Cassia fistula Linn leaves was carried using methanol as solvent. The percentage yield of the methanol extract of the leaves of Cassia fistula Linn was found to be 15.9% w/w.
4.2 Phytochemical Screening:
Preliminary phytochemical screening of Cassia fistula Linn leaves revealed the presence of flavonoids, glycosides, tannins and phenolic as shown in Table 1.
Table: 1 Preliminary Phytochemical Screening
S.NO |
CHEMICAL TEST |
RESULTS |
1 |
Alkaloids |
- |
2 |
Carbohydrates |
- |
3 |
Flavonoids |
+ |
4 |
Saponins |
- |
5 |
Tannins and phenolics |
+ |
6 |
Steroids and Triterpenoids |
- |
7 |
Amino acid |
- |
8 |
Glycosides |
+ |
Group |
Dose (mg / ml) |
% inhibition |
IC50 (mg / ml) |
MCF |
1 2 4 8 16 32 64 |
8.390 ± 2.907 22.380 ± 4.22 43.970 ± 5.501 55.460 ± 5.501 59.243 ± 8.225 65.927 ± 1.424 72.83 ± 1.654 |
6.23 ± 0.34
|
Indomethacin |
1 2 4 8 16 32 64 |
3.22 ± 0.87 20.280 ± 3.20 39.875 ± 4.432 49.764 ± 5.522 55.870 ± 7.220 63.876 ± 2.324 73.564 ± 1.531 |
7.18 ± 0.76
|
Table: 2 5-Lipoxygenase Inhibition Assay Of Methanol Extract Of Cassia Fistula Linn
Group |
Dose (mg / ml) |
Enzyme activity |
% inhibition |
IC50 (mg / ml) |
MCF |
1 2 4 8 16 32 |
2.817 ± 0.043 2.570 ± 0.106 1.943 ± 0.1133 1.381 ± 0.0597 0.976 ± 0.0069 0.77 ± 0.101 |
11.037 ± 1.357 18.85 ± 3.345 38.66 ± 3.576 64.37 ± 1.913 69.187 ± 0.213 75.69 ± 3.182 |
7.1 ± 0.34 |
Indomethacin |
1 2 4 8 16 32 |
2.932 ± 0.100 2.612 ± 0.045 1.960 ± 0.103 1.129 ± 0.060 0.8913 ± 0.229 0.5863 ± 0.057 |
7.787 ± 3.078 17.503 ± 1.380 43.647 ± 8.47 64.37 ± 1.913 75.917 ± 0.213 81.49 ± 1.825 |
6.5 ±0 .74 |
Table: 3 12-Lipoxygenase Inhibition Assay Of Methanol Extract Of Cassia Fistula Linn
Methanolic Extract Of Cassia Fistula Linn:
Group |
Dose (µg / ml) |
% inhibition |
IC50 (µg / ml) |
MCF
|
10 50 100 200 |
17 ± 2 38.33 ± 3.05 56.33 ± 5.508 64.66 ± 4.508 |
89.54 ± 0.73 |
Ibuprofen
|
10 50 100 200 |
21.33± 1.528 46.66 ± 3.215 65 ± 2 78 ± 5.56 |
60.32 ± 0.63
|
Table: 4 Human Red Blood Cells (HRBC) Membrane Stabilisation Method Using Methanolic Extract Of Cassia Fistula Linn
Sample |
Concentration (µg/ml) |
% inhibition |
IC50(µg/ml) |
MCF |
50 100 200 400 800 |
19.227 ± 4.405 29.170 ± 2.535 47.21 ± 1.097 66.667 ± 3.613 85.29 ± 3.199 |
315 ± 0.65 |
Ascorbic acid |
50 100 200 400 800 |
26.92 ± 2.07 45.517 ± 0.9023 66.007 ± 2.315 78.833 ± 1.085 91.327 ± 2.624 |
154 ± 0.45 |
Table: 5 DPPH Radical Scavenging Activity Of Cassia Fistula Linn Methanol Extract Of Leaves
Sample |
Conc (µg/ml) |
% inhibition |
IC50 (µg/ml) |
MCF
|
50 100 150 200 250 |
28.05 ± 0.802 35.70 ± 1.018 47.37 ± 1.344 58.40 ± 1.534 67.70 ± 1.71 |
172 ± 0.50 |
Quercetin
|
50 100 150 200 250 |
22.93 ± 1.25 38.72 ± 0.98 42.52 ± 0.70 50 ± 0.5657 58.82 ± 1.131 |
190 ± 0.71 |
Table: 6 Hydroxyl Radical Scavenging Activity Of Cassia Fistula Linn Leaves Methanol Extract
Sample |
Conc (µg/ml) |
% Inhibition |
IC50 (µg/ml) |
MCF |
20 40 60 80 100 |
24.6 ± 0.848 37.25 ± 0.35 51.4 ± 1.273 56.65 ± 0.91 67.9 ± 0.707 |
59 ± 0.33 |
Ascorbic acid |
20 40 60 80 100 |
47.35 ± 1.612 51.37 ± 1.259 63.32 ± 2.121 77.85 ± 1.464 81.15 ± 1.88 |
39 ± 0.49 |
Table: 7 Superoxide Radical Scavenging Assay Using Cassia Fistula Linn Leaves Methanol Extract
Sample |
Concentration (µg/ml) |
Absorbance |
MCF |
50 100 200 400 800 |
0.1770 ± 0.005 0.2377 ± 0.00416 0.324 ± 0.001 0.4287 ± 0.0152 0.5387 ± 0.0143 |
BHT (Butylated hydroxyl toluene) |
50 100 200 400 800 |
0.2297 ± 0.01662 0.342 ± 0.0185 0.4753 ± 0.0113 0.9847 ± 0.01206 01.73 ± 0.03647 |
Table: 8 Reducing Power Assay Of Cassia Fistula Linn Leaves Methanol Extract
Sample |
Conc (µg/ml) |
% Inhibition |
IC50 (µg/ml) |
MCF |
50 150 250 350 450 |
32.86 ± 0.5657 39.185 ± 1.308 51.050 ± 2.277 58.315 ± 1.407 66.855 ± 2.020 |
247 ± 0.42
|
Curcumin Standard
|
50 150 250 350 450 |
36.165 ± 0.926 56.365 ± 6.300 62.6 ± 1.725 73.775 ± 1.577 82.621 ± 0.595 |
147 ± 0.54 |
Table: 9 Nitric Oxide Radical Scavenging Assay Using Methanol Extract Of Cassia Fistula Linn Leaves
CONCLUSION
In conclusion, there has been a growing interest in the alternative medicine and the therapeutic properties of the natural products derived from plants in the recent years. The leaves of Cassia fistula Linn leaves were extracted with methanol and phytochemical screening was carried out with the extract. The leaf extract was found to contain flavonoid, glycosides, tannins and phenolics. Based on the various in vitro methods carried out, it can be concluded that Cassia fistula Linn leaves posses anti-inflammatory activity. In addition, in order to test whether the plant posses’ anti-platelet activity, an in vitro method was carried out and it was found to posses’ anti-platelet activity similar to aspirin (NSAID). The anti-oxidant activity was also carried out using various in vitro methods and was found to be a good anti-oxidant. Further studies using in vivo models are necessary to confirm these activities and to explore the exact mechanism by which the plant constituents act.
REFERENCE
P. Karthik*, S. Swetha, P. Saranya, L. Gopi, Dr. V. Kalvimoorthi, In Vitro Anti-Inflammatory, Antiplatelet, And Antioxidant Activities of Cassia Fistula Linn Leaves, Int. J. Sci. R. Tech., 2024, 1 (12), 179-185. https://doi.org/10.5281/zenodo.14437206